Alternatives to Genentech (Roche)

Genentech (Roche) is a Biotech tool: pioneering biotechnology company focused on discovering, developing, manufacturing, and commercializing medicines to treat patients with serious or life-threatening medical conditions. Here are the 59 closest alternatives, compared on pricing, features and what real users say.

Genentech (Roche) profile More Biotech alternatives

The 20 closest Biotech companies to Genentech (Roche)

LTZ Therapeutics
Not rated
Immunotherapy company targeting oncology and autoimmune diseases.
Visit site
Manifold Bio
Not rated
AI-guided drug discovery platform for tissue-targeted medicines.
Visit site
TippingPoint Biosciences
Not rated
Developing novel therapeutics targeting dysfunctional DNA packaging for diseases like cancer.
Visit site
Hexagon Bio
Not rated
Developing novel therapeutics by understanding the complex interplay of biological systems.
Visit site
Avidity Biosciences
Not rated
Clinical-stage biotechnology company developing Antibody Oligonucleotide Conjugates (AOCs) for serious diseases.
Visit site
Adaptam Therapeutics
Not rated
Developing novel therapeutics for rare genetic diseases with a focus on protein degradation.
Visit site
Sutro Biopharma
Not rated
Clinical-stage biopharma developing precisely designed cancer therapeutics using a proprietary cell-free protein synthesis platform.
Visit site
Nona Biosciences
Not rated
Biotechnology company specializing in antibody discovery and development with integrated 'Idea to IND' solutions.
Visit site
Amgen
Not rated
A global biotechnology company discovering, developing, manufacturing, and delivering innovative human therapeutics.
Visit site
Denali Therapeutics
Not rated
Biopharmaceutical company developing therapies for neurodegenerative diseases, focusing on crossing the blood-brain barrier.
Visit site
Adaptive Biotechnologies
Not rated
Leveraging the adaptive immune system to diagnose and treat disease.
Visit site
Cradle
Not rated
Cradle Bio B.V. is a Dutch, Swiss biotechnology company that develops software using machine learning for protein engineering. It was founded in 2021 and is base
Visit site
BeiGene
Not rated
A global oncology company developing and commercializing innovative cancer treatments.
Visit site
Vividion Therapeutics
Not rated
Biopharmaceutical company developing novel therapeutics for cancer and other diseases using chemoproteomics and covalent chemistry.
Visit site
Paratus Sciences
Not rated
Biotech startup leveraging bat biology for novel therapeutics in immunology and cardiometabolic diseases.
Visit site
Lexeo Therapeutics
Not rated
Clinical-stage genetic medicine company developing AAV-mediated treatments for cardiovascular and Alzheimer's diseases.
Visit site
Deep Genomics
Not rated
AI-powered biotechnology company developing RNA therapeutics for genetic diseases.
Visit site
Moleculent
Not rated
Mapping cell-cell communication at scale in human tissue.
Visit site
Dinamo Biotechnologies
Not rated
Developing novel protein engineering tools for advanced biomanufacturing and therapeutics.
Visit site
NewLimit
Not rated
NewLimit is developing epigenetic therapies to extend human healthspan by reprogramming aging cells.
Visit site

Company	Rating	Visit
LTZ TherapeuticsImmunotherapy company targeting oncology and autoimmune diseases.	Not rated	Visit site
Manifold BioAI-guided drug discovery platform for tissue-targeted medicines.	Not rated	Visit site
TippingPoint BiosciencesDeveloping novel therapeutics targeting dysfunctional DNA packaging for diseases like cancer.	Not rated	Visit site
Hexagon BioDeveloping novel therapeutics by understanding the complex interplay of biological systems.	Not rated	Visit site
Avidity BiosciencesClinical-stage biotechnology company developing Antibody Oligonucleotide Conjugates (AOCs) for serious diseases.	Not rated	Visit site
Adaptam TherapeuticsDeveloping novel therapeutics for rare genetic diseases with a focus on protein degradation.	Not rated	Visit site
Sutro BiopharmaClinical-stage biopharma developing precisely designed cancer therapeutics using a proprietary cell-free protein synthesis platform.	Not rated	Visit site
Nona BiosciencesBiotechnology company specializing in antibody discovery and development with integrated 'Idea to IND' solutions.	Not rated	Visit site
AmgenA global biotechnology company discovering, developing, manufacturing, and delivering innovative human therapeutics.	Not rated	Visit site
Denali TherapeuticsBiopharmaceutical company developing therapies for neurodegenerative diseases, focusing on crossing the blood-brain barrier.	Not rated	Visit site
Adaptive BiotechnologiesLeveraging the adaptive immune system to diagnose and treat disease.	Not rated	Visit site
CradleCradle Bio B.V. is a Dutch, Swiss biotechnology company that develops software using machine learning for protein engineering. It was founded in 2021 and is base	Not rated	Visit site
BeiGeneA global oncology company developing and commercializing innovative cancer treatments.	Not rated	Visit site
Vividion TherapeuticsBiopharmaceutical company developing novel therapeutics for cancer and other diseases using chemoproteomics and covalent chemistry.	Not rated	Visit site
Paratus SciencesBiotech startup leveraging bat biology for novel therapeutics in immunology and cardiometabolic diseases.	Not rated	Visit site
Lexeo TherapeuticsClinical-stage genetic medicine company developing AAV-mediated treatments for cardiovascular and Alzheimer's diseases.	Not rated	Visit site
Deep GenomicsAI-powered biotechnology company developing RNA therapeutics for genetic diseases.	Not rated	Visit site
MoleculentMapping cell-cell communication at scale in human tissue.	Not rated	Visit site
Dinamo BiotechnologiesDeveloping novel protein engineering tools for advanced biomanufacturing and therapeutics.	Not rated	Visit site
NewLimitNewLimit is developing epigenetic therapies to extend human healthspan by reprogramming aging cells.	Not rated	Visit site

Showing the next 20 closest matches. See the rest on the Genentech (Roche) profile.

Sponsored rows are paid and labelled. Advertise on this page